Literature DB >> 32725466

A case of solitary subependymal giant cell astrocytoma with histopathological anaplasia and TSC2 gene alteration.

Mario Suzuki1, Akihide Kondo2, Ikuko Ogino1, Osamu Akiyama1, Naohide Fujita1, Yuzaburo Shimizu1, Hajime Arai1.   

Abstract

We report a case of subependymal giant cell astrocytoma (SEGA) with anaplastic histological features in a 3-year-old girl. She had no clinical manifestations of tuberous sclerosis complex (TSC) and no relevant family history. A few cases have been reported in which patients with SEGA had no other clinical manifestations of TSC (solitary SEGA). Genetic analysis using a blood sample from the patient showed no germline alterations in TSC1 or TSC2 genes, while the tumor tissue exhibited loss of heterozygosity (LOH) in TSC2. SEGAs are benign, slowly growing tumors that rarely have significant mitotic activity. However, histopathological examination in the present case revealed high mitotic activity and necrosis besides the typical large plump cells arranged in sheets. This may be the first genetically proven case of a solitary SEGA with histopathological anaplastic features. In this report, we reviewed solitary SEGAs and histopathological malignancy in SEGA.

Entities:  

Keywords:  Anaplasia; Astrocytoma; Loss of heterozygosity; Tuberous sclerosis

Mesh:

Year:  2020        PMID: 32725466     DOI: 10.1007/s00381-020-04839-5

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  2 in total

1.  Subependymal giant cell astrocytoma: clinical, histologic and immunohistochemical characteristic of 3 cases.

Authors:  A Taraszewska; H Kroh; A Majchrowski
Journal:  Folia Neuropathol       Date:  1997       Impact factor: 2.038

2.  Subependymal giant cell astrocytomas with atypical histological features mimicking malignant gliomas.

Authors:  Wiesława Grajkowska; Katarzyna Kotulska; Elżbieta Jurkiewicz; Marcin Roszkowski; Paweł Daszkiewicz; Sergiusz Jóźwiak; Ewa Matyja
Journal:  Folia Neuropathol       Date:  2011       Impact factor: 2.038

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.